Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Regional Cancer Care Associates›
Website
AddedFeb 15, 2024
UpdatedJun 28, 2026
Regional Cancer Care Associates

Regional Cancer Care Associates

Regional Cancer Care Associates: Providing advanced, personalized care for oncology patients.

HQ
Hackensack, NJ, US
Founded
2012
Loading
Overview
Compare
Employees
Website

Regional Cancer Care Associates - Website

An index of every page on regionalcancercare.org, by section.

15 pages across 5 sections · Updated Jul 16, 2026·

Homepage

Regional Cancer Care Associates's front door: current positioning and top-line messaging.

regionalcancercare.org

Contact

Sales, support, and partnership channels for reaching Regional Cancer Care Associates directly.

regionalcancercare.org/contact

ComparisonRccas Move from Mt Holly to Moorestown Promises an Even More Convenient and Patient Centric Experience

6 comparison pages published by Regional Cancer Care Associates.

  • Rccas Move from Mt Holly to Moorestown Promises an Even More Convenient and Patient Centric Experience
  • Chemotherapy vs Immunotherapy They Re Not the Same
  • Colonoscopy vs Ct Colonography Differences and Advantages
  • External vs Internal Radiation for Breast Cancer
  • A Phase 3 Randomized Open Label Multicenter Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination with Physicians Choice Chemotherapy Compared to Trastuzumab in Combi
  • An Open Label Randomized Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physicians Choice in Hormone Receptor Positive Her2 Negative Unresectable Locally Advanced

BlogNews

Product updates, deep-dives, and company thinking: Regional Cancer Care Associates's 6-post archive.

regionalcancercare.org/news
  • Rccas Dr Iuliana Shapira Presents at the 2020 Komen New Jersey Virtual Metastatic Breast Cancer Conference
  • Fredrick Smith M D Recipient of Lungevity Face of Hope Award
  • Speaking at National Conference Rcca CEO Terrill Jordan Highlights Keys to Success of New Medicare Cancer Services Reimbursement Model
  • Rcca President and CEO Terrill Jordan to Share Insights at Patient Centered Oncology Care Conference 2020
  • Cancer and Covid 19 What to Know

PrivacyPrivacy Policy

How Regional Cancer Care Associates collects, uses, and safeguards data: the canonical policy set.

regionalcancercare.org/privacy-policy